Ranata Therapeutics
Ranata Therapeutics builds antibodies and bispecific antibodies against the unique features of an individual patient's cancer cells.
Overview
Ranata Therapeutics harnesses the uniqueness of a patient's cancer cells to build biologic therapies, antibodies or bispecifics, against that cancer: personalised medicine inspired by the individual's biology. It is an Even One Ventures portfolio company with no published candidates.
Funding
All startupsSimilar pages
not linked directly; found by shared links- CompanyRelit Biosciences
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyEcho Immune
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyYuga Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyInvocata
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyMinuteman Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyValius Sciences
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyKernis Health
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyPalitra Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.